AUSTIN: The North American consortium, Alzheimer’s Disease Cooperative Study (ADCS), recently completed a phase II clinical trial to test the efficiency of a novel drug T-817MA (Chemical Name: 1-{3-[2-(1-benzothiophen-5-yl)ethoxy] propyl}-3-azetidinol maleate). Researchers at Clinical Trials of Texas (CTT) and the University of North Texas Health Read More »

SAN FRANCISCO: More Alzheimer’s research continues to expose new, interesting, and very important ideas about not only how we could potentially treat the condition but also what its origins may be. A new study appears to indicate that a simply immune system disorder may, at Read More »

AUSTIN: The first drugs to treat hearing conditions such as tinnitus could be available in the next five years, according to a new report.

With five drugs already in the final stages of clinical testing and a further 13 in the early stages of clinical Read More »

NEW YORK: As antibiotics act to inhibit the growth of bacteria, the drugs are useful for treating bacterial infectious diseases. However, microorganisms that produce antibiotics must be protected from the lethal effect of their own antibiotic product.

In this review, the fruit of our group’s Read More »